Jun 25, 2026
15 MIN READ

What’s the Average Weight Loss on Wegovy?

Semaglutide users in clinical trials lost 10-22% of body weight over 68 weeks, with most seeing steady progress after 4-8 weeks of treatment. Your individual results depend on dose, lifestyle, and genetic factors—PlexusDx helps match you to the right therapy.

GLP-1 weight loss starts at $129/mo Provider-reviewed options. No membership fees.

See if you qualify →

Jun 25, 2026
15 MIN READ

what’s the average weight loss on wegovy? — PlexusDx GLP-1 education

Last reviewed: June 25, 2026

Last updated: June 25, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide has become the most recognized GLP-1 medication for weight loss, used by millions seeking lasting results without extreme diet restrictions. Clinical trials show participants lost an average of 15% of their starting body weight, though individual outcomes range significantly based on dosage, adherence, and metabolic differences. PlexusDx offers compounded semaglutide injections starting at $149 per month, allowing you to access proven weight loss therapy without insurance barriers or membership fees.

Clinical Trial Results for Semaglutide Weight Loss

The landmark STEP trials followed thousands of patients taking semaglutide for 68 weeks. Participants receiving the highest maintenance dose (2.4 mg weekly) lost approximately 22% of their body weight on average, while those on lower doses saw reductions of 10-15%. These studies included people with obesity and those with type 2 diabetes, showing consistent efficacy across populations.

Real-world outcomes often mirror trial data when patients maintain consistent weekly injections and combine treatment with modest dietary changes. Weight loss typically accelerates between weeks 4 and 12, then continues at a steady rate through month 6. Plateaus are common after 6-12 months, but many patients maintain their reduced weight long-term with continued therapy.

How Semaglutide Produces Weight Loss Results

Semaglutide mimics glucagon-like peptide-1 (GLP-1), a natural hormone that signals fullness to your brain and slows stomach emptying. This dual action reduces hunger and calorie intake without requiring willpower-dependent restriction. Most patients report feeling satisfied with smaller meals and experiencing fewer cravings within 1-2 weeks of starting treatment.

The medication also improves blood sugar control, which helps stabilize energy levels and reduce metabolic inflammation. This metabolic improvement supports continued weight loss even when calorie deficit plateaus. Unlike stimulant-based appetite suppressants, semaglutide works with your body's natural hunger regulation system, making sustainable weight management more achievable.

Factors Affecting Your Individual Weight Loss on Semaglutide

Your starting weight, age, baseline metabolism, and genetic makeup all influence how much weight you lose. People with a higher starting weight typically see larger absolute weight loss, while percentage-based loss tends to be similar. Genetic variations in GLP-1 receptor sensitivity and appetite regulation pathways mean some patients respond more dramatically than others to the same dose.

Lifestyle integration matters significantly—patients combining semaglutide with consistent physical activity and protein-focused nutrition lose more weight than those relying on medication alone. Sleep quality, stress levels, and medication compliance also impact outcomes. PlexusDx's Precision Peptide Genetic Test ($99 add-on after your first month) analyzes key variants in GLP1R, GIPR, FTO, and MC4R genes to help predict your individual response and optimize dosing strategy.

Timeline: When to Expect Weight Loss on Semaglutide

Most patients notice appetite reduction and early weight loss within 7-14 days of their first injection. The first 4 weeks typically show 2-5 pounds of loss as your body adjusts and calorie intake naturally decreases. By week 8, cumulative weight loss usually reaches 5-10 pounds for patients on maintenance doses, with continued progress every 4 weeks.

Maximal weight loss typically occurs between months 4-8 of consistent treatment. Some patients plateau after 6 months and maintain that loss indefinitely with continued therapy. Discontinuing semaglutide usually leads to gradual weight regain over 12-24 months, so many patients view this as long-term maintenance therapy rather than a temporary intervention. PlexusDx supports continuous access with flat monthly pricing—your dose may increase, but your price won't.

Comparing Semaglutide to Other GLP-1 Options

Tirzepatide (a GLP-1/GIP dual agonist) produces slightly larger average weight losses (21-23%) compared to semaglutide alone, though both are highly effective. Oral semaglutide requires higher doses for similar results and has variable absorption, making injections more predictable for weight loss. PlexusDx offers both compounded semaglutide injections ($149/mo) and tirzepatide injections ($249/mo), plus combination therapy through GLP-Squared ($249/mo injection or $369/mo oral).

The choice depends on your preference for injection frequency, desired weight loss magnitude, and budget. Semaglutide requires once-weekly injections, while tirzepatide also uses weekly dosing but may produce faster results for some patients. PlexusDx's genetic testing helps identify which GLP-1 pathway variant (GLP1R vs. GIPR sensitivity) might make you a better responder to each option.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What's a realistic amount of weight to lose on semaglutide?

Most patients lose 10-22% of their starting body weight over 68 weeks, with an average of around 15%. Individual results vary based on your dose, adherence, starting weight, and lifestyle factors. PlexusDx personalized dosing helps maximize your individual potential.

How long does it take to see weight loss results on semaglutide?

Appetite reduction typically appears within 1-2 weeks, with measurable weight loss (2-5 pounds) visible by week 4. Significant cumulative loss (10+ pounds) usually appears by 8-12 weeks of consistent treatment. Maximum weight loss occurs between months 4-8.

Does semaglutide work for everyone?

Semaglutide is effective for most people, but response varies. Some patients are natural responders with robust weight loss, while others see slower results. Genetic factors in your GLP-1 receptor and appetite-regulating pathways influence your response—the PlexusDx Precision Peptide Genetic Test identifies these predispositions to help optimize your therapy.

How much does compounded semaglutide cost at PlexusDx?

PlexusDx compounded semaglutide injections start at $149 per month, with no insurance requirement, no membership fee, and HSA/FSA eligibility. Your dose may increase over time, but your monthly price remains flat. All medications come from licensed 503A compounding pharmacies.

What happens if I stop taking semaglutide?

Weight typically returns gradually over 12-24 months after discontinuing semaglutide, as appetite hormones normalize. Many patients view semaglutide as long-term maintenance therapy rather than a short-term fix. PlexusDx supports continuous access with simple month-to-month flexibility and affordable flat pricing.

Can genetic testing predict how much weight I'll lose on semaglutide?

The PlexusDx Precision Peptide Genetic Test analyzes variants in GLP1R, GIPR, FTO, and MC4R genes across 14 metabolic pathways to predict your individual GLP-1 responsiveness and weight loss potential. While genetics explain part of the variation, lifestyle and adherence also matter significantly.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves